ZURA BIO LIMITED (ZURA) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$29.34M*; Operating income -$29.32M; Depreciation and amortization -$15.97K*.
- 2026-03-31: Basis Reported; EBITDA -$25.48M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$18.4M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$19.49M*; Operating income -$19.52M; Depreciation and amortization $33.98K*.
Complete source-backed ebitda history.
- Available history
- 2024-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$29.34M* | -$29.32M | -$15.97K* | (m) | (m) | -$12.96K* | $18.88M* | (m) | $20.71M | (m) | -$81.00K |
|---|
| 2026-03-31 | Reported | -$25.48M | (m) | (m) | (m) | (m) | $13.00K | -$18.92M | (m) | $14.75M | (m) | $0.00 |
|---|
| 2025-12-31 | Reported | -$18.4M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$19.49M* | -$19.52M | $33.98K* | (m) | (m) | $95.94K* | -$42.51M* | (m) | $11.95M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$18.07M* | -$18.06M | -$8.98K* | (m) | (m) | -$48.94K* | $11.04M* | (m) | $8.70M | (m) | $0.00 |
|---|
| 2025-03-31 | Reported | -$19.25M | (m) | (m) | (m) | (m) | $49.00K | -$11.06M | (m) | $10.47M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$15.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$19.32M* | -$19.32M | $3.00K* | (m) | (m) | $13.00K* | -$5.65M* | (m) | $6.03M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$11.76M | (m) | (m) | (m) | $10.00K* | -$6.62M* | (m) | $5.54M | (m) | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$8.38M | (m) | (m) | (m) | $7.00K | -$4.98M | (m) | $3.59M | (m) | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$10.19M | (m) | (m) | (m) | (m) | -$2.57M* | (m) | $3.96M | (m) | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$33.91M | (m) | (m) | (m) | (m) | -$5.17M* | (m) | $28.23M | (m) | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$7.72M | (m) | (m) | (m) | (m) | -$3.26M | (m) | $4.88M | (m) | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$1.07M | (m) | (m) | (m) | (m) | (m) | (m) | $415.00K | (m) | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$927.00K | (m) | (m) | (m) | (m) | (m) | (m) | $85.00K | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$412.33K | (m) | (m) | (m) | (m) | -$214.62K | (m) | (m) | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$7.82M | (m) | (m) | (m) | (m) | -$280.00K | (m) | $7.50M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$321.86K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$19.14K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$75.2M | (m) | (m) | (m) | (m) | $113.00K | -$64.81M | (m) | $42.08M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$55.18M | (m) | (m) | (m) | (m) | $75.00K | -$28.08M | (m) | $24.40M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | (m) | -$62.64M | (m) | (m) | (m) | (m) | -$15.05M | (m) | $44.00M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | (m) | -$2.68M | (m) | (m) | (m) | (m) | -$1.07M | (m) | (m) | (m) | (m) |
|---|